The Government of Canada’s investment will support the research and development of FloPatch, clinical trials, and preliminary market development
Flosonics Medical is pleased to announce that it has received $200,000 from the Government of Canada to develop a non-invasive ultrasound sensor aimed at improving the clinical management of critically ill patients.
The Canadian medical device company headquartered in Sudbury, Ontario will use the funding to support the research and development of FloPatch, a wireless, wearable Doppler ultrasound system.
The investment provided through FedNor’s Northern Ontario Development Program will also support clinical trials and preliminary market development.
“This exciting initiative will allow us to capitalize on an immediate opportunity to develop a wearable medical device that will enable healthcare providers to better care for critically ill patients,” said Andrew Eibl, co-founder and COO of Flosonics Medical.
“We are pleased to partner with the Government of Canada to develop our FloPatch technology and we look forward to the positive impact it will have on healthcare delivery in Canada and beyond.”
Minister of Innovation, Science and Economic Development Navdeep Bains said the Government of Canada invested in Flosonics Medical because the company’s technology has the potential to modernize and improve patient care.
“This strategic initiative supports our government’s Innovation and Skills Plan by investing in product development, as well as people and businesses to further position our nation as world-leader in the innovation economy, helping to create jobs and grow the middle class,” he said.
Sudbury Member of Parliament Paul Lefebvre said he is thrilled that FedNor is investing in Flosonics Medical to create a made-in-Northern Ontario solution to help improve patient care.
“Today’s announcement highlights our government’s commitment to support research and innovation in the region, while helping companies bring new products to market,” he said.